.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
A systematic review and meta-analysis of randomized and observational studies compared surgical with conservative treatment for cervical spondylotic myelopathy. Although postoperative JOA scores were not uniformly different between groups, the surgical group showed greater improvement and a higher recovery rate overall. The findings suggest that surgery may provide more neurological recovery in appropriate patients, while also showing how differences in baseline severity and study design can influence conclusions. For HCPs, the paper is best used to frame rather than dictate treatment. Patients with progressive or clinically meaningful myelopathy may gain from decompression, but the magnitude of benefit depends on disease severity, duration and individual anatomy. Conservative treatment may still be reasonable for mild, stable cases under close observation. The evidence also highlights the limits of pooled observational data, especially when surgical patients begin with more severe disease. A careful neurological examination remains essential, and treatment should be based on clinical progression rather than imaging severity alone. The practical message is to combine patient phenotype, trajectory and evidence quality when discussing the timing of cervical decompression.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A systematic review and meta-analysis of randomized and observational studies compared surgical with conservative treatment for cervical spondylotic myelopathy. Although postoperative JOA scores were not uniformly different between groups, the surgical group showed greater improvement and a higher recovery rate overall. The findings suggest that surgery may provide more neurological recovery in appropriate patients, while also showing how differences in baseline severity and study design can influence conclusions. For HCPs, the paper is best used to frame rather than dictate treatment. Patients with progressive or clinically meaningful myelopathy may gain from decompression, but the magnitude of benefit depends on disease severity, duration and individual anatomy. Conservative treatment may still be reasonable for mild, stable cases under close observation. The evidence also highlights the limits of pooled observational data, especially when surgical patients begin with more severe disease. A careful neurological examination remains essential, and treatment should be based on clinical progression rather than imaging severity alone. The practical message is to combine patient phenotype, trajectory and evidence quality when discussing the timing of cervical decompression.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
